P742: Clinician survey on VUS reporting in panel genetic testing
Genetics in Medicine Open · 2025 · 3 · 103111
DOI: 10.1016/j.gimo.2025.103111 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genetics in Medicine Open, 2025. Verfasst von Andreea Popa und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The field of genetic testing has evolved in the past decade, with broader clinical indications and more genes assessed in panels. The reporting practices have not evolved similarly, leading to high rates of variants of uncertain significance (VUS), many with low likelihood to be disease-causing. For exome sequencing analysis, reporting is focused on the clinical presentation and generally results in a limited number of variants. While few laboratories follow the same practice for panels, many laboratories still report all VUS, irrespective of inheritance or clinical phenotype, creating unnecessary burden on clinicians and patients.
Zitieren
APA
Popa, A., Stubbs, D., Bell, S., Jacoby, E., Mayo, P., & Wang, L. (2025). P742: Clinician survey on VUS reporting in panel genetic testing. Genetics in Medicine Open, 3, 103111. https://doi.org/10.1016/j.gimo.2025.103111
Vancouver
Popa A, Stubbs D, Bell S, Jacoby E, Mayo P, Wang L. P742: Clinician survey on VUS reporting in panel genetic testing. Genetics in Medicine Open. 2025;3:103111. doi:10.1016/j.gimo.2025.103111
BibTeX
@article{Popa2025,
author = {Popa, Andreea and Stubbs, Douglas and Bell, Sarah and Jacoby, Ellie and Mayo, Ping and Wang, Lijun},
title = {P742: Clinician survey on VUS reporting in panel genetic testing},
journal = {Genetics in Medicine Open},
year = {2025},
volume = {3},
pages = {103111},
doi = {10.1016/j.gimo.2025.103111}
}
EUVIMED